Sterility Tests Summary Precautions Against Microbial Contamination
Sterility Tests Summary Precautions Against Microbial Contamination
Sterility Tests Summary Precautions Against Microbial Contamination
Aseptic technique must be employed in performing sterility tests. The working conditions must be regularly
monitored and sampling process should be appropriate.
Fluid A
- contains peptic digest, pH of 7.1 ± 0.2
- added to ”Preparation for Penicillins or Cephalosporins”
Fluid D
- Fluid A + polysorbate 80, pH of 7.1 ± 0.2
- used for articles containing lecithin or oil, or for devices labeled as “sterile pathway”
Fluid K
- peptic digest + beef extract + polysorbate 80, pH of 6.9 ± 0.2
Membrane Filtration
Use membrane filters having a nominal pore size not
greater than 0.45 µm, in which the effectiveness to
retain microorganisms has been established.
Aqueous Solutions
Transfer the contents of the container or containers to be tested to the membrane or membranes, if
necessary, after diluting to the volume used in the Method Suitability Test with the chosen sterile diluent, but
using not less than the quantities of the product to be examined prescribed in Tables 2 and 3. Filter
immediately. If the product has anti-microbial properties, wash the membrane not less than three times by
filtering through it each time the volume of the chosen sterile diluent used in the Method Suitability Test.
Soluble Solids
Use for each medium not less than the quantity prescribed in Tables 2 and 3 of the product dissolved in a
suitable solvent, such as the solvent provided with the preparation, Sterile Water for Injection, sterile saline,
or a suitable sterile solution such as Fluid A (Diluting and Rinsing Fluids for Membrane Filtration), and proceed
with the test as de-scribed above for Aqueous Solutions using a membrane appropriate to the chosen solvent.
Use for each medium not less than the quantity of the product prescribed in Tables 2 and 3. Oils and oily
solutions of sufficiently low viscosity may be filtered without dilution through a dry membrane. Viscous oils
may be diluted as necessary with a suitable sterile diluent such as isopropyl myristate shown not to have
antimicrobial activity in the conditions of the test. Allow the oil to penetrate the mem-brane by its own weight,
and then filter, applying the pressure or suction gradually. Wash the membrane at least three times by filtering
through it each time about 100 mL of a suitable sterile solution such as Fluid A (see Diluting and Rinsing Fluids
for Membrane Filtration) containing a suitable emulsifying agent at a concentration shown to be appropriate
in the Method Suitability Test, for example polysorbate 80 at a concentration of 10 g per L (Fluid K). Transfer
the membrane or membranes to the culture medium or media, or vice versa, as described above for Aqueous
Solutions, and incubate at the same temperatures and for the same times.
Use for each medium not less than the quantities of the product prescribed in Tables 2 and 3. Ointments in a
fatty base and emulsions of the water-in-oil type may be diluted to 1% in isopropyl myristate as described
eat to not
more than 44. Filter as rapidly as possible, and proceed as described above for Oils and Oily Solutions.
Prefilled Syringes
Expel the contents of each syringe into one or two separate membrane filter funnels or into separate pooling
vessels prior to transfer. If a separate sterile needle is attached, directly expel the syringe contents as indicated
above, and proceed as directed for Aqueous Solutions. Test the sterility of the needle, using Direct Inoculation
under Method Suitability Test.
Constitute the test articles as directed on the label, and proceed as directed for Aqueous Solutions or Oils and
Oily Solutions, whichever applies.
Pharmacy Bulk Packages, <5 g—From each of 20 con-tainers, aseptically transfer about 300 mg of solids, into
a sterile 500-mL conical flask, dissolve in about 200 mL of Fluid A (see Diluting and Rinsing Fluids for Membrane
Filtra-tion), and mix; or constitute, as directed in the labeling, each of 20 containers and transfer a quantity of
liquid or suspension, equivalent to about 300 mg of solids, into a sterile 500-mL conical flask, dissolve in about
200 mL of Fluid A, and mix. Proceed as directed for Aqueous Solutions or Oils and Oily Solutions, whichever
applies.
Pharmacy Bulk Packages, ˃5 g—From each of 6 containers, aseptically transfer about 1 g of solids into a sterile
500-mL conical flask, dissolve in about 200 mL of Fluid A, and mix; or constitute, as directed in the labeling,
each of 6 containers and transfer a quantity of liquid, equivalent to about 1 g of solids, into a sterile 500-mL
conical flask, dis-solve in about 200 mL of Fluid A, and mix. Proceed as directed for Aqueous Solutions.
For fluid products in pressurized aerosol form, freeze the containers in an alcohol-dry ice mixture at least at –
20C for about 1 hour. If feasible, allow the propellant to escape before aseptically opening the container, and
transfer the contents to a sterile pooling vessel. Add 100 mL of Fluid D to the pooling vessel, and mix gently.
Proceed as directed for Aqueous Solutions or Oils and Oily Solutions, whichever applies.
Oily Liquids
Solids
Sterile Devices